Login / Signup

Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy.

Rodolfo V CurielWilliam NguyenGulnara MamyrovaDerek JonesAlison EhrlichKathleen A BrindleShahriar Haji-MomenianRobert SheetsHanna KimOlcay Y JonesLisa G Ridernull null
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
This open-label study demonstrated abatacept may be beneficial for treatment-refractory JDM.
Keyphrases